Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Lyra Therapeutics, Inc. (LYRA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
10 Nov 2023
Waksal Harlan
Executive Chair, Director, Officer
Lyra Therapeutics, Inc.
(LYRA)
261,966
+10%
25,000
$2.96
$74,095.00
BUY
31 May 2023
ANDERSON EDWARD T
Director, 10% Owner
Lyra Therapeutics, Inc.
(LYRA)
2,259,301
+397%
1,805,416
$2.43
$4,387,161.00
BUY
31 May 2023
PERCEPTIVE ADVISORS LLC
Director, 10% Owner
Lyra Therapeutics, Inc.
(LYRA)
11,469,117
+45%
3,610,832
$2.49
$8,999,999.00
BUY
31 May 2023
NBVM GP, LLC
10% Owner
Lyra Therapeutics, Inc.
(LYRA)
2,259,301
+397%
1,805,416
$2.43
$4,387,161.00
BUY
10 Jun 2022
MERRIFIELD C ANN
Director
Lyra Therapeutics, Inc.
(LYRA)
11,328
+54%
4,000
$5.05
$20,200.00
BUY
13 May 2022
MERRIFIELD C ANN
Director
Lyra Therapeutics, Inc.
(LYRA)
7,328
+109%
3,828
$4.83
$18,485.50
BUY
12 Apr 2022
PERCEPTIVE ADVISORS LLC
Director, 10% Owner
Lyra Therapeutics, Inc.
(LYRA)
7,858,285
+306%
5,924,170
$4.22
$24,999,996.00
BUY
12 Apr 2022
NBVM GP, LLC
10% Owner
Lyra Therapeutics, Inc.
(LYRA)
1,855,443
+460%
2,369,667
$4.22
$9,999,994.00
BUY
12 Apr 2022
Waksal Harlan
Executive Chair, Director, Officer
Lyra Therapeutics, Inc.
(LYRA)
236,966
+100%
236,966
$4.22
$999,996.50
BUY
12 Apr 2022
ANDERSON EDWARD T
Director, 10% Owner
Lyra Therapeutics, Inc.
(LYRA)
1,855,443
+393%
2,488,150
$4.22
$10,499,992.00
BUY
17 Jun 2021
MERRIFIELD C ANN
Director
Lyra Therapeutics, Inc.
(LYRA)
3,500
+100%
3,500
$8.97
$31,394.65
BUY
16 Dec 2020
snyderman nancy lynn MD
Director
Lyra Therapeutics, Inc.
(LYRA)
1,025
+100%
1,025
$9.72
$9,963.00
BUY
5 May 2020
Polaris Venture Management Co. V, L.L.C.
10% Owner
Lyra Therapeutics, Inc.
(LYRA)
1,001,951
+5%
52,826
$16.00
$845,216.00
BUY
5 May 2020
Soleus Private Equity GP I, LLC
10% Owner
Lyra Therapeutics, Inc.
(LYRA)
457,421
+43%
138,091
$16.00
$2,209,456.00
BUY
5 May 2020
PERCEPTIVE ADVISORS LLC
Director, 10% Owner
Lyra Therapeutics, Inc.
(LYRA)
1,934,115
+47%
625,000
$16.00
$10,000,000.00
BUY
5 May 2020
NBVM GP, LLC
10% Owner
Lyra Therapeutics, Inc.
(LYRA)
661,153
+51%
225,817
$16.00
$3,613,072.00
BUY
5 May 2020
ANDERSON EDWARD T
Director, 10% Owner
Lyra Therapeutics, Inc.
(LYRA)
661,153
+51%
225,817
$16.00
$3,613,072.00
Home